Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.85 USD | +1.09% |
|
+14.20% | -87.43% |
06-24 | Amylyx Pharmaceuticals, Inc.(NasdaqGS:AMLX) dropped from S&P Pharmaceuticals Select Industry Index | CI |
06-21 | Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.43% | 126M | |
+2.77% | 94.22B | |
-3.42% | 37.76B | |
-13.75% | 32.5B | |
+73.19% | 27.75B | |
-11.88% | 16.13B | |
+0.49% | 14.19B | |
-12.95% | 11.42B | |
+190.36% | 11.06B | |
-54.07% | 9.09B |
- Stock Market
- Equities
- AMLX Stock
- News Amylyx Pharmaceuticals, Inc.
- Mizuho Downgrades Amylyx Pharmaceuticals to Neutral From Buy After Negative Results From Phase 3 PHEONIX Study, Adjusts PT to $4 From $32